Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 27, 2014
Sep. 28, 2013
Operating activities    
Net loss $ (4,473) $ (14,309)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 6,833 9,736
Amortization of intangible assets 316 299
Impairment loss on property and equipment 0 4,832
Impairment loss on intangible assets 0 1,245
Deferred income taxes 60 109
Share-based compensation expense 1,691 1,065
Stock awards issued for non-employee director service 0 31
Amortization of deferred financing costs 61 61
Gain from disposition of assets (21) (39)
Changes in operating assets and liabilities:    
Accounts receivable 1,071 2,536
Inventory (7,830) 2,550
Other current assets 106 475
Other non-current assets (9) 142
Accounts payable and accrued expenses 2,869 (10,303)
Other current liabilities 227 (864)
Other non-current liabilities (191) 515
Net cash provided by (used in) operating activities 710 (1,919)
Investing activities    
Additions to property and equipment (4,292) (6,679)
Proceeds from sale of property and equipment 27 42
Cash paid for intangible assets (200) 0
Purchases of marketable securities and investments (746) (4)
Proceeds from the sale of marketable securities and investments 745 0
Purchases of company-owned life insurance 0 (106)
Net cash used in investing activities (4,466) (6,747)
Financing activities    
Borrowings from revolving loan payable 14,233 16,667
Payments made on revolving loan payable (10,138) (24,590)
Proceeds from sale leaseback transaction 0 9,584
Proceeds from issuance of Series A convertible preferred stock 0 6,017
Payment of issuance costs from Series A convertible preferred stock 0 (847)
Proceeds from issuance of common stock 0 2,235
Payment of issuance costs from common stock 0 (223)
Payments on capital leases (170) (126)
Proceeds from exercise of stock options 265 22
Net cash provided by financing activities 4,190 8,739
Effect of exchange rate changes on cash 3 (4)
Net change in cash and cash equivalents 437 69
Cash and cash equivalents, beginning of period 818 1,030
Cash and cash equivalents, end of period 1,255 1,099
Supplemental disclosure of non-cash investing and financing activities:    
Accrued asset purchases 801 848
Property acquired under capital lease 0 322
Unrealized gain on investments 70 4
Supplemental disclosure of cash flow information:    
Cash received during the period for income taxes 34 32
Cash paid during the period for interest $ (744) $ (628)